BMC Cardiovascular Disorders (Jan 2024)

Cut-off value for interleukin-34 as an additional potential inflammatory biomarker for estimation of slow coronary flow risk

  • Mehdi Karasu,
  • Hasan Ata Bolayır

DOI
https://doi.org/10.1186/s12872-023-03677-y
Journal volume & issue
Vol. 24, no. 1
pp. 1 – 7

Abstract

Read online

Abstract Background Inflammatory markers may provide insights into the underlying mechanisms of slow coronary flow (SCF), including subclinical atherosclerosis and endothelial dysfunction. Interleukin-34 (IL-34), known for its role in immuno-inflammatory diseases, might hold significance in SCF. We aimed to explore the potential association between IL-34 and SCF in patients undergoing diagnostic elective coronary angiography. Methods This observational, cross-sectional study enrolled 256 participants: 124 with SCF and 132 with normal coronary flow (NCF). All participants had undergone outpatient coronary angiography for suspected coronary artery disease. SCF assessment employed the TIMI frame count (TFC) for quantifying coronary flow rate. Results SCF patients exhibited significantly elevated TFC in all three major coronary arteries compared to controls (p 0.05]. Similarly, high-sensitivity C-reactive protein (hsCRP) showed a significant and positive relationship with average TFC [for all participants: r = 0.504, p 0.05]. SCF patients presented coronary arteries of larger size compared to controls. Conclusion Mean coronary diameter and IL-34 emerged as independent predictors of SCF. Additionally, hsCRP, mean coronary diameter, and IL-34 exhibited a positive correlation with mean TFC values. IL-34 appears to be a more effective indicator than hsCRP in SCF patients.

Keywords